NEOGENOMICS INC (NEO) Stock Fundamental Analysis
NASDAQ:NEO - Nasdaq - US64049M2098 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to NEO. NEO was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of NEO have multiple concerns. NEO is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
NEO had positive earnings in the past year.
In the past year NEO had a positive cash flow from operations.
NEO had negative earnings in 4 of the past 5 years.
In multiple years NEO reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -4.84%, NEO is doing worse than 67.65% of the companies in the same industry.
NEO has a Return On Equity (-8.73%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.84% | ||
| ROE | -8.73% | ||
| ROIC | N/A |
ROA(3y)-6.11%
ROA(5y)-3.67%
ROE(3y)-10.84%
ROE(5y)-6.53%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NEO has a better Gross Margin (44.30%) than 73.53% of its industry peers.
NEO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NEO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.3% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.37%
GM growth 5Y-1.82%
2. Health
2.1 Basic Checks
NEO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NEO has more shares outstanding
The number of shares outstanding for NEO has been increased compared to 5 years ago.
Compared to 1 year ago, NEO has a worse debt to assets ratio.
2.2 Solvency
NEO has an Altman-Z score of 1.03. This is a bad value and indicates that NEO is not financially healthy and even has some risk of bankruptcy.
NEO has a worse Altman-Z score (1.03) than 69.61% of its industry peers.
NEO has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NEO (0.38) is better than 62.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.03 |
ROIC/WACCN/A
WACC6.6%
2.3 Liquidity
NEO has a Current Ratio of 2.05. This indicates that NEO is financially healthy and has no problem in meeting its short term obligations.
NEO's Current ratio of 2.05 is fine compared to the rest of the industry. NEO outperforms 74.51% of its industry peers.
NEO has a Quick Ratio of 1.95. This is a normal value and indicates that NEO is financially healthy and should not expect problems in meeting its short term obligations.
NEO has a better Quick ratio (1.95) than 73.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.95 |
3. Growth
3.1 Past
NEO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 400.00%, which is quite impressive.
NEO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.25% yearly.
Looking at the last year, NEO shows a quite strong growth in Revenue. The Revenue has grown by 10.10% in the last year.
Measured over the past years, NEO shows a quite strong growth in Revenue. The Revenue has been growing by 10.07% on average per year.
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5Y-20.25%
EPS Q2Q%100%
Revenue 1Y (TTM)10.1%
Revenue growth 3Y10.9%
Revenue growth 5Y10.07%
Sales Q2Q%7.55%
3.2 Future
Based on estimates for the next years, NEO will show a very strong growth in Earnings Per Share. The EPS will grow by 77.14% on average per year.
NEO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.24% yearly.
EPS Next Y80.54%
EPS Next 2Y83.37%
EPS Next 3Y77.14%
EPS Next 5YN/A
Revenue Next Year12.59%
Revenue Next 2Y11.88%
Revenue Next 3Y11.24%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 66.58 indicates a quite expensive valuation of NEO.
NEO's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.60, NEO is valued quite expensively.
Based on the Price/Forward Earnings ratio of 23.76, the valuation of NEO can be described as rather expensive.
NEO's Price/Forward Earnings is on the same level as the industry average.
NEO's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.43.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.58 | ||
| Fwd PE | 23.76 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
NEO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NEO's earnings are expected to grow with 77.14% in the coming years.
PEG (NY)0.83
PEG (5Y)N/A
EPS Next 2Y83.37%
EPS Next 3Y77.14%
5. Dividend
5.1 Amount
No dividends for NEO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.99
-0.07 (-0.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.16%
Inst Owner Change3.63%
Ins Owners1.14%
Ins Owner Change1.79%
Market Cap1.03B
Analysts77.89
Price Target11.09 (38.8%)
Short Float %3.73%
Short Ratio2.13
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)67.51%
Min EPS beat(2)35.03%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)326.2%
Min EPS beat(4)35.03%
Max EPS beat(4)871.51%
EPS beat(8)8
Avg EPS beat(8)217.51%
EPS beat(12)12
Avg EPS beat(12)158.96%
EPS beat(16)16
Avg EPS beat(16)126.24%
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-2.68%
Max Revenue beat(2)-1.66%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.68%
Max Revenue beat(4)0.63%
Revenue beat(8)5
Avg Revenue beat(8)1.5%
Revenue beat(12)9
Avg Revenue beat(12)2.54%
Revenue beat(16)10
Avg Revenue beat(16)1.69%
PT rev (1m)-39.58%
PT rev (3m)-46.3%
EPS NQ rev (1m)-21.21%
EPS NQ rev (3m)-28.44%
EPS NY rev (1m)-0.84%
EPS NY rev (3m)-10.32%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.51%
Revenue NY rev (1m)0.79%
Revenue NY rev (3m)1.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.58 | ||
| Fwd PE | 23.76 | ||
| P/S | 1.53 | ||
| P/FCF | N/A | ||
| P/OCF | 135.1 | ||
| P/B | 1.16 | ||
| P/tB | 30.08 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.12
EY1.5%
EPS(NY)0.34
Fwd EY4.21%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.06
OCFY0.74%
SpS5.22
BVpS6.9
TBVpS0.27
PEG (NY)0.83
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.84% | ||
| ROE | -8.73% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.3% | ||
| FCFM | N/A |
ROA(3y)-6.11%
ROA(5y)-3.67%
ROE(3y)-10.84%
ROE(5y)-6.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.37%
GM growth 5Y-1.82%
F-Score6
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 55.52% | ||
| Cap/Sales | 5.95% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.05 | ||
| Quick Ratio | 1.95 | ||
| Altman-Z | 1.03 |
F-Score6
WACC6.6%
ROIC/WACCN/A
Cap/Depr(3y)46.9%
Cap/Depr(5y)68.48%
Cap/Sales(3y)5.71%
Cap/Sales(5y)7.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3YN/A
EPS 5Y-20.25%
EPS Q2Q%100%
EPS Next Y80.54%
EPS Next 2Y83.37%
EPS Next 3Y77.14%
EPS Next 5YN/A
Revenue 1Y (TTM)10.1%
Revenue growth 3Y10.9%
Revenue growth 5Y10.07%
Sales Q2Q%7.55%
Revenue Next Year12.59%
Revenue Next 2Y11.88%
Revenue Next 3Y11.24%
Revenue Next 5YN/A
EBIT growth 1Y9.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.76%
EBIT Next 3Y48.9%
EBIT Next 5YN/A
FCF growth 1Y60.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y115.33%
OCF growth 3YN/A
OCF growth 5Y-21.37%